US FDA grants Breakthrough Therapy Designation to Pfizer’s Respiratory Syncytial Virus vaccine candidate Read more
US FDA grants breakthrough therapy designation to Roche’s anti-amyloid beta antibody gantenerumab Read more
FDA grants BTD for Venclexta in combination with azacitidine to treat patients with myelodysplastic syndromes Read more
Junshi Biosciences gets US FDA Breakthrough Therapy Designation for Toripalimab to treat nasopharyngeal carcinoma Read more